References
- Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9(12 Suppl):S16–S23.
- Liebman SE, Lamontagne SP, Huang LS, et al. Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity. Am J Kidney Dis. 2011;58(2):257–265.
- Staplin N, Haynes R, Herrington WG, et al. Smoking and adverse outcomes in patients with CKD: The Study of Heart and Renal Protection (SHARP). Am J Kidney Dis. 2016;68(3):371–380.
- Cselkó Z, Kovács G, Horváth I. The smoking situation in Hungary. Tob Induc Dis. 2018;16(1):100–100.
- Yugar-Toledo JC, Ferreira-Melo SE, Sabha M, et al. Blood pressure circadian rhythm and endothelial function in heavy smokers: acute effects of transdermal nicotine. J Clin Hypertens (Greenwich). 2005;7(12):721–728.
- Pittilo RM, Bull HA, Gulati S, et al. Nicotine and cigarette smoking: effects on the ultrastructure of aortic endothelium. Int J Exp Pathol. 1990;71(4):573–586.
- Cryer PE, Haymond MW, Santiago JV, et al. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med. 1976;295(11):573–577.
- Narkiewicz K, van de Borne PJ, Hausberg M, et al. Cigarette smoking increases sympathetic outflow in humans. Circulation. 1998;98(6):528–534.
- Powell JT. Vascular damage from smoking: disease mechanisms at the arterial wall. Vasc Med. 1998;3(1):21–28.
- Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol. 1997;29(7):1422–1431.
- Arany I, Taylor M, Fulop T, et al. Adverse effects of chronic nicotine exposure on the kidney: Potential human health implications of experimental findings. CP. 2018;56(11):501–506.
- Benowitz NL. The role of nicotine in smoking-related cardiovascular disease. Prev Med. 1997;26(4):412–417.
- Suskin N, Sheth T, Negassa A, et al. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;37(6):1677–1682.
- Fabbian F, Cantelli S, Molino C, et al. Dialysis initiation and survival in patients with refractory congestive heart failure. Int J Artif Organs. 2009;32(8):492–495.
- Tapolyai M, Karim J, Fakhruddin A. Escalating antihypertensive medications in end‐stage renal disease patients does not improve blood pressure control. J Clin Hypertension. 2008;10(3):215–218.
- Tapolyai M, Faludi M, Reti V, et al. Dialysis patients’ fluid overload, antihypertensive medications, and obesity. Asaio J. 2011;57(6):511–515.
- Agarwal R, Weir MR. Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients. CJASN. 2010;5(7):1255–1260.
- Mallamaci F, Benedetto FA, Tripepi R, et al. Detection of pulmonary congestion by chest ultrasound in dialysis patients. JACC Cardiovasc Imaging. 2010;3(6):586–594.